<bill session="112" type="h" number="6702" updated="2013-07-20T02:07:44-04:00">
  <state datetime="2012-12-20">REFERRED</state>
  <status>
    <introduced datetime="2012-12-20"/>
  </status>
  <introduced datetime="2012-12-20"/>
  <titles>
    <title as="introduced" type="official">To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes.</title>
  </titles>
  <sponsor id="400439"/>
  <cosponsors>
    <cosponsor id="400663" joined="2012-12-20"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2012-12-20">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, In Committee"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Blood and blood diseases"/>
    <term name="Medical ethics"/>
    <term name="Organ and tissue donation and transplantation"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary>12/20/2012--Introduced.
Amends the National Organ Transplant Act to prohibit acquiring, receiving, or otherwise transferring a cord blood unit (the neonatal blood collected from the placenta and umbilical cord of a single newborn baby) for valuable consideration for use in human transplantation if the transfer affects interstate commerce.</summary>
</bill>
